Lijnen et al., 1996 - Google Patents
Staphylokinase, a fibrin-specific bacterial plasminogen activatorLijnen et al., 1996
- Document ID
- 838520969563581623
- Author
- Lijnen H
- Collen D
- Publication year
- Publication venue
- Fibrinolysis
External Links
Snippet
Plasminogen activators have been classified as' fibrinspecific'or'non fibrin-specific'. 1 Non fibrin-specific plasminogen activators such as streptokinase, anisoylated plasminogen streptokinase activator complex (APSAC) and two-chain urokinase-type plasminogen …
- 101700010221 sak 0 title abstract description 169
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
- A61K38/49—Urokinase; Tissue plasminogen activator
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/164—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/305—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F)
- C07K14/31—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F) from Staphylococcus (G)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- C12N9/6424—Serine endopeptidases (3.4.21)
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Collen | Staphylokinase: a potent, uniquely fibrin-selective thrombolytic agent | |
Collen et al. | Staphylokinase, a fibrin-specific plasminogen activator with therapeutic potential? | |
US5759542A (en) | Compositions and methods for the delivery of drugs by platelets for the treatment of cardiovascular and other diseases | |
Collen et al. | Coronary thrombolysis with recombinant staphylokinase in patients with evolving myocardial infarction. | |
Collen | The plasminogen (fibrinolytic) system | |
Lijnen et al. | Staphylokinase, a fibrin-specific bacterial plasminogen activator | |
US5328996A (en) | Bacterial plasmin receptors as fibrinolytic agents | |
US20050136045A1 (en) | Identification, production and use of staphylokinase derivatives with reduced immunogenicity and/or reduced clearance | |
US5695754A (en) | Staphylokinase derivatives | |
AU705119B2 (en) | New staphylokinase derivatives | |
US6759042B2 (en) | Use of cross-linked, covalently bound urokinase plasminogen activator (scuPA)-urokinase plasminogen activator receptor (suPAR) complex as a fibrinolytic agent | |
Torréns et al. | A mutant streptokinase lacking the C-terminal 42 amino acids is less reactive with preexisting antibodies in patient sera | |
Verstraete et al. | Novel thrombolytic agents | |
US6902733B2 (en) | Staphylokinase derivatives with polyethyleneglycol | |
Pâques | Streptokinase or urokinase: The choice between them | |
Hernández et al. | Streptokinase: about of a thrombolytic patented in Cuba | |
Vanderschueren et al. | Recombinant staphylokinase for thrombolytic therapy | |
Collen et al. | 10 New thrombolytic agents and strategies | |
EP0721013B1 (en) | New staphylokinase derivatives | |
JP3399963B2 (en) | New staphylokinase derivatives | |
Lijnen et al. | Staphylokinase | |
Collen et al. | Staphylokinase, a fibrin-specific plasminogen activator with | |
WO1992018139A1 (en) | Chimeric molecule with plasminogen activator activity and affinity for atherosclerotic plaques | |
Lijnen et al. | Genetically Engineered New Thrombolytic Agents | |
Lijnen et al. | Fibrinolytic properties of staphylokinase mutants obtained by ‘clustered charge-to-alanine’mutagenesis |